Neovacs appoints Florence Hocdée-Leroy as Director of Communications and Investor Relations
Michel Finance steps down as CFO, to be proposed to the Board of Directors at the AGM
Neovacs announced the appointment of Florence Hocdée-Leroy as Communications and Investor Relations Director.
Ms. Hocdée-Leroy brings the company her international experience and her expertise in corporate communications, the financial markets and investor relations. After graduating from EM Lyon, she started her career at Rhone-Poulenc, the French pharmaceutical and chemical Group, where she used to lead financial communication and investor relations. Subsequently, she worked at KBC securities as a sell-side analyst covering the pharmaceutical sector from 1999 to 2003, before joining the Grosvenor Group, with responsibility for Communications and Marketing for Continental Europe.
Neovacs also announces that Michel Finance has stepped down as Deputy CEO and CFO of Neovacs. He joined the Company in November 2009 to lead the process of the Company’s Initial Public Offering on Alternext.
Other news from the department people
